Disrupting CARMA3 Signaling with Triptolide Reverses Sorafenib Resistance in Hepatocellular Carcinoma.
Saved in:
| Title: | Disrupting CARMA3 Signaling with Triptolide Reverses Sorafenib Resistance in Hepatocellular Carcinoma. |
|---|---|
| Authors: | Wang WY; Division of General Surgery, Department of Surgery, Shuang Ho Hospital, Taipei Medical University, New Taipei City 235, Taiwan., Hsu TW; Division of General Surgery, Department of Surgery, Shuang Ho Hospital, Taipei Medical University, New Taipei City 235, Taiwan.; Graduate Institute of Medical Sciences, College of Medicine, Taipei Medical University, Taipei 110, Taiwan., Su YH; Division of General Surgery, Department of Surgery, Shuang Ho Hospital, Taipei Medical University, New Taipei City 235, Taiwan.; TMU Research Center of Cancer Translational Medicine, Taipei Medical University, Taipei 110, Taiwan.; Division of General Surgery, Department of Surgery, School of Medicine, College of Medicine, Taipei Medical University, Taipei 110, Taiwan.; TMU Research Center for Digestive Medicine, Taipei Medical University, Taipei 110, Taiwan.; Graduate Institute of Clinical Medicine, College of Medicine, Taipei Medical University, Taipei 110, Taiwan.; Metabolic and Weight Management Center, Shuang Ho Hospital, Taipei Medical University, New Taipei City 235, Taiwan., Su CM; Division of General Surgery, Department of Surgery, Shuang Ho Hospital, Taipei Medical University, New Taipei City 235, Taiwan.; Division of General Surgery, Department of Surgery, School of Medicine, College of Medicine, Taipei Medical University, Taipei 110, Taiwan., Wang TH; Division of General Surgery, Department of Surgery, Shuang Ho Hospital, Taipei Medical University, New Taipei City 235, Taiwan., Chiu CF; Division of General Surgery, Department of Surgery, Shuang Ho Hospital, Taipei Medical University, New Taipei City 235, Taiwan., Tsai KY; Division of General Surgery, Department of Surgery, Shuang Ho Hospital, Taipei Medical University, New Taipei City 235, Taiwan.; TMU Research Center of Cancer Translational Medicine, Taipei Medical University, Taipei 110, Taiwan.; Division of General Surgery, Department of Surgery, School of Medicine, College of Medicine, Taipei Medical University, Taipei 110, Taiwan.; TMU Research Center for Digestive Medicine, Taipei Medical University, Taipei 110, Taiwan., Huang CY; Cardiovascular and Mitochondrial Related Disease Research Center, Hualien Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation, Hualien970, Taiwan.; Department of Medical Research, China Medical University Hospital, China Medical University, Taichung 404, Taiwan.; Department of Biotechnology, Asia University, Taichung 413, Taiwan.; Graduate Institute of Biomedical Science, China Medical University, Taichung 404 Taiwan.; Institute of Medical Sciences, Tzu Chi University, Hualien 970, Taiwan., Chen HA; Division of General Surgery, Department of Surgery, Shuang Ho Hospital, Taipei Medical University, New Taipei City 235, Taiwan.; TMU Research Center of Cancer Translational Medicine, Taipei Medical University, Taipei 110, Taiwan.; Division of General Surgery, Department of Surgery, School of Medicine, College of Medicine, Taipei Medical University, Taipei 110, Taiwan.; TMU Research Center for Digestive Medicine, Taipei Medical University, Taipei 110, Taiwan., Liao PH; Center for Drug Research and Development, College of Human Ecology, Chang Gung University of Science and Technology, Taoyuan 333, Taiwan. |
| Source: | International journal of medical sciences [Int J Med Sci] 2025 Oct 20; Vol. 22 (16), pp. 4353-4364. Date of Electronic Publication: 2025 Oct 20 (Print Publication: 2025). |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Ivyspring International Publisher Country of Publication: Australia NLM ID: 101213954 Publication Model: eCollection Cited Medium: Internet ISSN: 1449-1907 (Electronic) Linking ISSN: 14491907 NLM ISO Abbreviation: Int J Med Sci Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
